On-pump coronary artery bypass grafting for the treatment of multivessel diseases via left anterolateral minithoracotomy
- VernacularTitle:经左前外侧小切口不停跳冠状动脉旁路移植术治疗多支血管病变的临床研究
- Author:
Ritai HUANG
1
;
Genxing XU
1
;
Yongyi WANG
1
;
Jianggui SHAN
1
;
Wengang YANG
1
;
Song XUE
1
Author Information
1. Department of Cardiovascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P.R.China
- Publication Type:Journal Article
- Keywords:
Minithoracotomy;
coronary artery disease;
multivessel diseases;
on-pump coronary artery bypass grafting
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(02):182-185
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the safety and follow-up results of on-pump coronary artery bypass grafting (CABG) for the treatment of multivessel diseases via left anterolateral minithoracotomy. Methods From January 2018 to March 2020, a total of 30 patients including 18 males and 12 females with an average age of 61.3±7.5 years having multivessel coronary heart diseases were treated in our hospital with on-pump CABG via left anterolateral minithoracotomy. Among them, 14 patients had three-vessel diseases and 16 patients had two-vessel diseases. Results There were 29 internal mammary artery-to-left anterior descending bypass grafts harvested in total while the rest were saphenous-vein bypass grafts. The average number of bypass vessels was 2.3±0.5. There was no perioperative death in the whole group, one patient underwent rethoracotomy due to hemorrhage, and one patient suffered acute renal insufficiency. The average time of postoperative tracheal intubation was 16.0±5.8 hours, and the postoperative ICU stay was 30.1±11.5 hours. Twenty five patients were followed up, including coronary CT angiography examinations at 6 months and 1 year after operation. Proximal anastomotic stenosis in one patient and distal anastomosis occlusion in one patient occurred. Conclusion On-pump CABG via left anterolateral minithoracotomy is safe for appropriately selected patients.
